Amneal Pharmaceuticals

Amneal Pharmaceuticals

Pharmaceuticals
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

$6.5B

Market Cap • 10/23/2026

2017

(9 years)

Founded

2018

(8 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

197,1

P/S

2,1

P/EBITDA

10

P/OCF

32,4

P/FCF

78,3

P/E

41,6

BVPS

0,1

EPS

0,5

Market Cap

Market Cap

6,5B

EV

9,2B

EV/Revenue

3

EV/EBITDA

14,3

EV/EBIT

20,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0,7%

Total Yield

0,7%

Payout

0%

Retained Earnings

-415,1M

Profitability

Gross Margin

39,3%

EBITDA Margin

20,8%

EBIT Margin

14,6%

Net Margin

6,9%

D&A/EBITDA

0%

R&D/Revenue

5,9%

Capex/Revenue

3,8%

Capex/D&A

60,6%

Capex/OCF

58,6%

SBC/OCF

17,7%

% PPE

15%

% Goodwill

15,7%

ROE

609,4%

ROIC

16,7%

Growth

CAGR Revenue 5Y

8,7%

CAGR Op. Income 5Y

27,3%

CAGR Net Income 5Y

64,8%

CAGR EPS 5Y

52,2%

CAGR OCF 5Y

-4,1%

Leverage

N.D./EBITDA

4,1

Debt/Equity

0%

Current Ratio

2,2

Quick Ratio

1,3

Interest Coverage

199,6%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium